8 results on '"Daniel Lentz"'
Search Results
2. Business Interruption: Coverage, Claims, and Recovery, 2nd Edition
- Author
-
Daniel Lentz
- Published
- 2012
3. The Procter & Gamble Company: Investment in Crest Whitestrips Advanced Seal
- Author
-
Daniel Lentz and Michael J. Schill
- Subjects
Product (business) ,Crest Whitestrips ,Shareholder ,Brand extension ,Downtown ,business.industry ,Business ,Marketing ,Investment (macroeconomics) ,Net present value ,Marketing strategy - Abstract
A financial analyst for Procter & Gamble must report on the prospects and implications of a new teeth-whitening product. Beyond a realistic profit-and-loss forecast and baseline net present value, he must determine which pricing and marketing strategy is most likely to maximize value for shareholders. Excerpt UVA-F-1670 Rev. Dec. 7, 2016 The Procter & Gamble Company: Investment in Crest Whitestrips Advanced Seal It was May 2008, and Jackson Christopher, a financial analyst for the Procter & Gamble Company's (P&G) North America Oral Care (NAOC) group, hustled along a sunny downtown Cincinnati street on his way to work. NAOC's Crest teeth whitening group was considering the launch of an extension to its Whitestrips product, and the project had dominated most of his working hours. At least he avoided a long commute by living downtown. The week before, the group had met to consider the merits of the proposed product, known as Crest Advanced Seal. Although openly intrigued by the concept, Angela Roman, the group's general manager (GM), was reserving judgment until she had a clearer picture of the idea and risks. She had tasked Christopher with putting together the economic perspective on Advanced Seal, an effort that had required a lot of work amalgamating all the different considerations and thinking through the financial implications. In the process, he had had to manage a lot of different constituencies. In short, it had been an interesting week, and with the follow-up meeting the next day, Christopher knew he needed to present some conclusions. . . .
- Published
- 2017
- Full Text
- View/download PDF
4. Gadopentetate Dimeglumine as an Intradiscal Contrast Agent
- Author
-
James F. Zucherman, Michael B. Shapiro, John Gartland, Ken Y. Hsu, Timothy S. Huang, and Daniel Lentz
- Subjects
Gadolinium DTPA ,medicine.medical_specialty ,Gadolinium ,Radiography ,Contrast Media ,Iothalamate Meglumine ,chemistry.chemical_element ,Discography ,Iodinated Contrast Agent ,Wrist ,Sensitivity and Specificity ,Iodinated contrast ,Predictive Value of Tests ,medicine ,Humans ,Orthopedics and Sports Medicine ,Prospective Studies ,Intervertebral Disc ,Observer Variation ,medicine.diagnostic_test ,business.industry ,Drug Administration Routes ,Magnetic resonance imaging ,Magnetic Resonance Imaging ,Intervertebral disk ,medicine.anatomical_structure ,chemistry ,Spinal Diseases ,Neurology (clinical) ,Radiology ,Tomography, X-Ray Computed ,business ,Nuclear medicine ,Intervertebral Disc Displacement - Abstract
Study Design. Magnetic resonance discography using gadolinium as an intradiscal contrast agent was investigated in a prospective study. Objective. To evaluate the utility of magnetic resonance discography using gadolinium as an intradiscal contrast agent, as compared with the current standard of computed tomographic discography using intradiscal iodinated contrast agent. Summary of Background Data. Magnetic resonance arthrography with gadolinium has been used to evaluate shoulder, elbow, wrist, hip, knee, and other joints. Gadolinium has not been used as an intradiscal contrast agent. The authors’ preliminary results using gadolinium as an intradiscal contrast agent for magnetic resonance discography were reported previously. They report the results of their completed study. Methods. For this study, 42 disc levels were studied in 13 patients. Water-soluble iodinated contrast and gadopentetate dimeglumine were injected at each disc level. After discography, anteroposterior and lateral radiographs, computed tomography scans, and T1-weighted magnetic resonance imaging were performed. Six physicians interpreted the results from each disc level in a blinded fashion. Interscan and interobserver interpretation variability was determined for magnetic resonance discography and computed tomographic discography using the Pearson correlation-coefficient (r) test. Results. Interscan variability was highly correlated between computed tomographic discography and magnetic resonance discography when used to determine disc normality (r = 0.87), general degeneration (r = 0.87), anular fissure (r = 0.89), disc herniation (r = 0.92), and contrast leakage (r = 0.77). Interscan variability was assessed by the Pearson test, and all values of r for all the readers were noted to be statistically significant at P values less than 0.01. Interobserver variability was significantly correlated among the four more experienced readers (neuroradiologists and spine surgeons), but not among the spine fellows. Interobserver variability was also significantly correlated by computed tomographic (CT) and magnetic resonance imaging (MRI) discography for disc normality (CT r = 0.60; MRI r = 0.56), general degeneration (CT r = 0.76; MRI r = 0.71), anular fissure (CT r = 0.79; MRI r = 0.84), and disc herniation (CT r = 0.63; MRI r = 0.64). The readings for contrast leakage did not reach statistical significance for computed tomographic or magnetic resonance discography. Conclusions. The high interscan and interobserver correlation rates obtained for magnetic resonance discography using gadolinium, as compared with the standard computed tomographic discography technique, indicate that magnetic resonance discography may be an acceptable substitute for the imaging of disc pathology. Magnetic resonance discography with gadolinium can be recommended for patients allergic to iodinated contrast agents and for patients who wish to limit their radiation exposure.
- Published
- 2002
- Full Text
- View/download PDF
5. Business Interruption: Coverage, Claims, and Recovery, 2nd Edition
- Author
-
Daniel Lentz and Daniel Lentz
- Subjects
- Business income insurance, Insurance claims
- Abstract
Business interruption claims are some of the most challenging that insurance professionals, risk managers, and business owners face. Preparing for, managing, and closing out a business interruption claim can be complicated and frustrating and often ends in failure. Success requires that you understand accounting principles and are able to interpret coverage language that is sometimes indefinite. Only Business Interruption, 2nd Edition, delivers all of this, in one widely respected resource: An overview of the common elements of coverage Insights on customizing coverage Guides to establishing limits A step-by-step roadmap for handling the process from claim to settlement Specific techniques for calculating the business interruption loss Perspective of dispute resolution options And much more! Plus there are three entirely new chapters covering: FEMA Claims Recovery Beyond First-Party Property Coverage Claims in a Global Economy Plus! New Real-World Case Studies And much more! Learn Why Traditional Selling Doesn t Work Learn What You Need To Know To Win Rapport, Discovery, Differentiation The Six Steps of The Wedge Wedge Scripting Aids and More!
- Published
- 2011
6. Subject Index, Vol. 52, 1984
- Author
-
G L. Murison, Robert B. Owens, S D. Hall, Martin J. Murphy, A M. Lee, Daniel Lentz, Chen K. Chai, Akira Horikoshi, Eric Gershwin, Jyrki Heino, Charles Lerner, Timo Kouri, Huguette Løvtrup-Rein, and Markku Viander
- Subjects
Index (economics) ,Statistics ,Subject (documents) ,Cell Biology ,General Medicine ,Molecular Biology ,Pathology and Forensic Medicine ,Mathematics - Published
- 1984
- Full Text
- View/download PDF
7. Contents, Vol. 52, 1984
- Author
-
Chen K. Chai, Markku Viander, Robert B. Owens, Akira Horikoshi, Eric Gershwin, G L. Murison, Huguette Løvtrup-Rein, Charles Lerner, A M. Lee, Martin J. Murphy, Daniel Lentz, Timo Kouri, Jyrki Heino, and S D. Hall
- Subjects
Cell Biology ,General Medicine ,Molecular Biology ,Pathology and Forensic Medicine - Published
- 1984
- Full Text
- View/download PDF
8. Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor
- Author
-
Jonathan G. Seidman, Allan D. Duby, Daniel Lentz, Karen A. Klein, Zdenka Fronek, Peter H. Schur, and Nancy Berliner
- Subjects
Polymorphism, Genetic ,Immunology ,T-cell receptor ,Receptors, Antigen, T-Cell ,DNA ,Biology ,Molecular biology ,genomic DNA ,Rheumatology ,immune system diseases ,Humans ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,Pharmacology (medical) ,Restriction fragment length polymorphism ,skin and connective tissue diseases ,Gene ,Anti-SSA/Ro autoantibodies - Abstract
The genomic DNA polymorphism of the beta chain of the T cell receptor was examined. The restriction fragment length polymorphism distribution was similar in systemic lupus erythematosus patients, their relatives, and normal controls. Our observations suggest that these genes are not coinherited with genes responsible for systemic lupus erythematosus.
- Published
- 1986
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.